Former CEO Anne Wojcicki has successfully pushed for a higher purchase price for 23andMe, now reaching $305 million, after the company initially planned to sell to Regeneron for $256 million. This bid comes after Wojcicki's earlier offer of $40 million prior to the company's bankruptcy filing in March.
23andme ✓
bankruptcy ✓
acquisition ✓
wojcicki ✓
+ regneron